EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST: ECILC)

Market Cap	31.99B
Revenue (ttm)	6.16B
Net Income (ttm)	3.07B
Shares Out	685.26M
EPS (ttm)	4.47
PE Ratio	10.43
Forward PE	n/a
Dividend	1.18 (2.53%)
Ex-Dividend Date	Jun 5, 2024

Volume	1,343,849
Open	46.58
Previous Close	46.40
Day's Range	44.72 - 46.76
52-Week Range	39.92 - 64.80
Beta	-0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses primarily in Turkey. The Health segment produces and sells human health and veterinary drugs, as well as engages in pharmaceutical sales and marketing. The Real Estate Development segment develops real estate properties; engages in leasing activities for facilities; and provides consulting services regarding land development and project management. The company was incorporated in 1951 and...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 1,137
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ECILC

Financial Performance

In 2023, ECILC's revenue was 6.48 billion, an increase of 86.94% compared to the previous year's 3.47 billion. Earnings were 2.74 billion, a decrease of -8.16%.